California Resources Corporation heads into mid-August with its short sellers in notable retreat and options positioning at its most bullish extreme of the past year.
The clearest signal this week is the sharp unwinding of short positions. Shorts covering at an unusual pace tells the most interesting story: short interest fell 23% in a single week to 3.65% of the free float — roughly 3.1 million shares — the largest weekly decline in the 30-day history available. That compression follows a relatively stable positioning picture through July, when short interest held in a tight band around 3.9–4.0 million shares. The lending market offers no squeeze narrative here. Borrow availability sits at roughly 3,100% — meaning lenders hold around 31 shares for every share already borrowed — and cost to borrow is a negligible 0.48%, easing further over the past month. The absence of borrow pressure suggests this is genuine conviction covering, not a forced unwind.
Options pricing amplifies the bullish tilt. The put/call ratio dropped to 0.31 on Tuesday — more than three standard deviations below its 20-day average of 0.34. That's the most call-skewed reading of the past year, well below the 52-week trough of 0.14. For context, the PCR sat above 0.65 through the first week of July; the shift lower has been rapid and decisive. Earnings may be part of the backdrop: CRC reported Q2 results on August 10, and the stock gained roughly 3.9% on the day. The next print isn't until November 4, so this options lean likely reflects directional conviction rather than near-term event hedging.
The Street shares the constructive tone but has spent recent weeks trimming targets. UBS cut its price target to $67 from $70 yesterday while keeping a Buy rating — the firm's second reduction in a month, after lowering from $78 to $70 in mid-July. Barclays also lowered to $77 from $80 on Tuesday, maintaining Overweight. The direction of recent analyst moves is uniformly lower on targets despite unchanged positive ratings — a pattern that reflects softer oil price assumptions rather than any change in thesis. The consensus mean target still implies roughly 42% upside from the current $54.13 price. At a PE of 13.2x and EV/EBITDA of 4.7x — the latter up about 0.5x over the past 30 days as the share price has held while earnings estimates have drifted — valuation remains undemanding by sector standards. The EPS surprise factor score ranks in the 93rd percentile, a strong track record of beating estimates that supports the bullish analyst positioning.
Ownership is relatively concentrated. BlackRock leads with 13.5% of shares, followed by Canada Pension Plan entities holding a combined ~19% — the latter reported as of March 2026. Vanguard and State Street both added modestly in recent months. Insider activity has skewed toward selling: the Chief Commercial Officer sold roughly $643,000 worth of stock in mid-July, following a similar-sized sale in June. The COO has also been a consistent seller on award vesting dates. These are routine-looking disposition patterns rather than conviction sales, but the net insider position over 90 days reflects more shares sold than purchased.
Among close peers, GRNT and CRGY led the E&P group this week, gaining 8.6% and 10.1% respectively. MTDR added 7.8% and OXY 7.2%. CRC's 3.1% weekly gain was a relative laggard in that peer set, despite posting a solid post-earnings bounce — a gap worth watching given how aggressively short sellers covered.
With short interest at a multi-month low, options at their most call-heavy of the year, and the next earnings event three months out, the key variable for CRC now shifts to crude price direction and whether the Street's pattern of target reductions stabilises or accelerates into the autumn strip.
See the live data behind this article on ORTEX.
Open CRC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
